Search

You searched for "Gender"

536 results found
European Urology journal front cover with Editor's Choice stamp.

Keep it simple: a proposal for a new definition of uncomplicated and complicated UTIs

8 January 2025 | | URO - Infection
Urinary tract infections (UTIs) are one of the most common bacterial infections in both community and healthcare settings, leading to frequent antibiotic use. They range widely in severity, from mild cases like cystitis to severe, potentially life-threatening conditions such as...
European Urology journal front cover.

First and second-line treatments in metastatic renal cell carcinoma

2 May 2025 | | URO - Urologic Oncology
Over the past two decades, the treatment landscape for metastatic renal cell carcinoma (mRCC) has evolved significantly, leading to a quadrupling of patient survival rates. Modern systemic treatments include combinations of anti-PD-1 antibodies with either anti-CTLA-4 antibodies or antiangiogenic tyrosine...

New – unique 20ml pre-filled syringe hyaluronate GAG replenisher

5 November 2019 | Research & Development
Solatumfarma’s new sodium hyaluronate GAG replenisher offers to improve treatment for patients with chronic cystitis.

Richard Wolf Range Update

10 January 2020
Richard Wolf a global business with headquarters in Germany and over a century of tradition and expertise in the field of endoscopy. We develop, manufacture and market specific system solutions for minimally invasive human medicine.

Supporting chronic cystitis patients through the winter

1 October 2020 | Contracts & Distributors
The current pandemic is causing severe disruption to the care of patients with non-life-threatening conditions.

The assessment and medical treatment of LUTS secondary to BPH

1 November 2016 | URO - Functional / Reconstructive Urology
The term benign prostatic hyperplasia (BPH) describes prostate enlargement due to non-cancerous processes. Several aetiological mechanisms are involved, including hormonal and vascular alterations; abnormal regulation of apoptosis; and prostatic inflammation, which may stimulate cellular proliferation. With ageing, prostate enlargement can...

Józef Dietl – more than one crisis

5 September 2022 | | URO - Technology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). To urologists, the name Dietl is linked with the eponym of Dietl’s crisis,...

So you want to go on a fellowship – part II: the research year

1 November 2016 | | URO - Core Urology
This article is the second in a three-part series which follows directly on from the first part which concentrated on the rationale for going on a fellowship, as well as some of the administrative hurdles you might face in planning...

My UK reconstructive urology fellowship experience

8 November 2021 | | URO - Andrology, URO - Functional / Reconstructive Urology
Surgical training is a long and hard pathway. Having completed medical school, I undertook my internship at the Alfred Hospital in Melbourne. The Alfred Hospital is a leading tertiary teaching hospital in Australia’s second largest city. Prior to commencing my...

The process of medical innovation – evolving trends and future perspectives

5 May 2021 | | URO - Technology
In 2018 the United Kingdom Government spending on healthcare totalled almost £166 billion. Of this approximately 65% was attributed to providing curative or rehabilitation therapy, with health-related long-term care and provision of goods accounting for 25%. The remaining was accredited...

Frailty in urology – part 1

5 September 2022 | | URO - Endourology & Stones, URO - Functional / Reconstructive Urology, URO - Infection, URO - Trauma & Emergency, URO - Urologic Oncology
Part 2 of this topic can be found here Statement of the problem Clinical frailty carries an increased risk of poor health outcomes. The pathological process resulting in frailty is often overlooked and elucidating its aetiology and natural history are...

Management of stage 1 non-seminomatous germ cell tumours

1 November 2014 | | URO - Urologic Oncology
Testicular cancer (TC) is the most successfully treated solid tumour, achieving a cure rate of 90-95% [1-3]. Testicular cancer is relatively rare with an incidence of 2207 cases in the UK in 2014 [4] and yet is the most common...